Taylor Wealth Management Partners’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-107,381
Closed -$966K 60
2022
Q1
$966K Sell
107,381
-23,930
-18% -$230K 0.39% 47
2021
Q4
$1.48M Sell
131,311
-32,805
-20% -$410K 0.52% 40
2021
Q3
$2.4M Sell
164,116
-2,205
-1% -$33.6K 0.86% 39
2021
Q2
$2.72M Buy
166,321
+1,460
+0.9% +$27.2K 0.96% 36
2021
Q1
$3.32M Sell
164,861
-1,433
-0.9% -$34.4K 1.21% 33
2020
Q4
$3.42M Sell
166,294
-70
-0% -$1.29K 1.31% 28
2020
Q3
$2.94M Buy
166,364
+53,937
+48% +$857K 1.35% 29
2020
Q2
$1.91M Sell
112,427
-6,732
-6% -$85K 0.97% 37
2020
Q1
$1.16M Buy
+119,159
New +$1.54M 0.71% 35

Other funds holding PROF

Taylor Wealth Management Partners's PROF Position: Q2 2022 in Review

Taylor Wealth Management Partners sold out of Profound Medical (PROF) in Q2 2022, closing a stake of 107,381 shares — an estimated $966K sold.

Taylor Wealth Management Partners first reported a position in PROF in Q1 2020 and held it in 9 quarters. The position peaked at $3.42M in Q4 2020. 39 funds tracked by Wall St. Rank hold PROF as of Q2 2022.

  • Taylor Wealth Management Partners reported no remaining Profound Medical position as of Q2 2022 after selling out during the quarter.
  • Taylor Wealth Management Partners sold 107,381 Profound Medical shares in Q2 2022, an estimated $966K.
  • Taylor Wealth Management Partners first reported a position in Profound Medical in Q1 2020 and held it in 9 quarters.
  • Taylor Wealth Management Partners's Profound Medical position peaked at $3.42M in Q4 2020.
  • 39 funds tracked by Wall St. Rank held Profound Medical as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.